Pot-stock RotoGro scores first $1M from Miracle Valley
Roto-Gro World Wide (Canada) Inc., a wholly owned subsidiary of Roto-Gro International Limited (ASX:RGI), has received the first $1 million of the $2.3 million order secured from Miracle Valley Medicinal Alternatives M.V.M.A. Ltd.
The privately owned Miracle Valley is currently building a 29,000 square foot state-of-the-art cultivation and manufacturing facility in British Columbia, Canada.
The receipt of this first payment triggers the production of RotoGro Hydroponic Garden Systems, which are needed to complete the buildout of Miracle Valley’s facility. This buildout is also the final stage for Miracle Valley to obtain its medicinal cannabis production license from Health Canada.
RotoGro and Miracle Valley have agreed that the first delivery of RotoGro Hydroponic Garden Systems will kick off at the end of this quarter, with subsequent deliveries being made on a room-by-room basis through the second half of 2018, as Miracle Valley advances its Health Canada license through Introductory Inspection (as cultivation begins) to a License to Sell.
Once the facility is completed, it will produce up to 12,000 lbs (5,400 kilograms) of legal cannabis per year, harnessing RGI’s leading-edge patented and patent-pending designs, which provide the lowest cost per gram and the highest yield per square foot in the industry. The facility will utilise cutting-edge growing, building and information technologies to produce industry-leading yields, as well as the highest quality cannabis.
RGI managing director, Michael Carli said: “We are very pleased with the collaborative working relationship we have with Miracle Valley as it commences build-out, delivery and installation of our patented RotoGro Hydroponic Garden Systems.
“The success of this order is driven by the early engagement of RotoGro working ‘hand in glove’ with our clients to ensure they receive the best support from concept to design and build-out to production. Our team continues to work diligently with RotoGro’s prospective clients across the lawful cannabis and perishable foods space to nurture our sales pipeline for future orders.”
It’s worth noting here that RGI is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.